Truscreen Expands in China

Published: 06 May 2020

Highlights
• TruScreen device roll-out continues after COVID-19 restrictions lifted
• Four new hospitals added in Shanghai and Sichuan Province April 2020
• Distributor wins tender for five new hospitals to commence May 2020
• 18% increase in hospital coverage in April/May 2020

NZX Announcement

TruScreen Limited (NZX:TRU) (TruScreen or the “Company”) is pleased to advise that during April 2020 the TruScreen cervical screening device became operational in four new hospitals in the Shanghai Municipality and in Sichuan Province. These hospitals conducted around one hundred patient screening tests using TruScreen handheld real-time device during the month.TruScreen’s China distributor, Beijing Siweixiangtai Tech Co., Ltd (SWXT) was also successful in securing an order for supplying the TruScreen cervical screening device to a further five hospitals, for delivery and installation in May 2020. This increases the number of hospitals actively using the TruScreen cervical screening device on a commercial basis from forty nine to fifty eight, an 18% increase over March 2020.

Further roll outs of the TruScreen cervical screening device are expected for the rest of the calendar year.

TruScreen CEO, Victoria Potarina comments, “China continues to be our key focus and we are pleased with the current increase of hospital coverage. The adoption by these nine new hospitals of our TruScreen cervical screening system are a testament to the efficacy of the TruScreen cervical screening device. Our distributor, SWXT continues to work on the roll out of our Truscreen cervical screening programme in China, post COVID-19. We continue to see huge potential in this market.”

This announcement has been approved by the Board.

– ENDS –

TRU Expands In China Announcement.PDF